| p-p70S6K (n = 438) |  | ||
---|---|---|---|---|
 | Negative (n = 188) | Positive (n = 250) | P value | |
Treatment | No tamoxifen | 40 (21) | 55 (22) | 0.92a |
Tamoxifen 1 year | 89 (47) | 113 (45) | ||
Tamoxifen 3 years | 59 (31) | 82 (33) | ||
Age | <65 | 82 (44) | 128 (51) | 0.12b |
≥65 | 106 (56) | 122 (49) | ||
Lymph node | Negative | 92 (49) | 141 (56) | 0.12b |
Positive | 96 (51) | 109 (44) | ||
T stage | T1 to T2 | 167 (89) | 221 (88) | 1.00b |
T3 to T4 | 21 (11) | 29 (12) | ||
Grade | Grade 1 to 2 | 123 (65) | 153 (61) | 0.37b |
Grade 3 | 65 (35) | 97 (39) | ||
Progesterone receptor | Negative | 98 (52) | 111 (44) | 0.10b |
Positive | 88 (47) | 139 (56) | ||
Missing | 2 (1) | 0 (0) | ||
HER2 | Negative | 168 (89) | 223 (89) | 0.17b |
Positive | 12 (6) | 26 (10) | ||
Missing | 8 (4) | 1 (0) | ||
p-AKT(Ser473)c | Low (0 to 1) | 109 (71) | 53 (24) | <0.0001b |
High (2 to 3) | 44 (29) | 172 (76) | ||
p-AKT(Thr308)c | Negative | 143 (81) | 87 (36) | <0.0001b |
Positive | 34 (20) | 153 (64) | ||
p-mTORc | Low (0 to 59%) | 156 (87) | 176 (73) | 0.0003b |
High (≥60%) | 23 (13) | 66 (27) | ||
p-ERK1/2c | Negative | 114 (65) | 61 (26) | <0.0001b |
 | Positive | 61 (35) | 177 (74) |  |